CCL18 is known to increase the proliferation of B-cell lymphoma (Korbecki et al., 2020) and may contribute to immune evasion from its effect on immune surveillance mediated by macrophages and dendritic cells and by simultaneously favoring T cell-tolerance (Korbecki et al., 2020; Cardoso et al., 2021; Kidani et al., 2022). This evidence concerns the gene CCL18 and B-cell non-Hodgkin lymphoma.